Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
以安慰剂为对照评价慢盆康灌肠液治疗盆腔炎性疾病后遗症(慢性盆腔痛)的安全性和有效性
[Translation] Evaluation of the safety and efficacy of Manpenkang enema solution in the treatment of sequelae of pelvic inflammatory disease (chronic pelvic pain) using placebo as a control
以安慰剂为对照进一步评价慢盆康灌肠液治疗(湿热瘀毒蕴结证)盆腔炎性疾病后遗症(慢性盆腔痛)的安全性和有效性
[Translation] To further evaluate the safety and efficacy of Manpenkang enema solution in the treatment of sequelae of pelvic inflammatory disease (chronic pelvic pain) (syndrome of damp-heat and stasis) with placebo as control
100 Clinical Results associated with Shaanxi Jingwei Group Co., Ltd.
0 Patents (Medical) associated with Shaanxi Jingwei Group Co., Ltd.
100 Deals associated with Shaanxi Jingwei Group Co., Ltd.
100 Translational Medicine associated with Shaanxi Jingwei Group Co., Ltd.